000			03893nam a22003975i 4500
999			_c100302 _d100302 _x1
001			100302
003			DE-He213
005			20230104123547.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			171013s2018 it | s |||| 0|eng d
020			_a9788847039551
024	7		_a10.1007/978-88-470-3955-1 _2doi
040			_aES-MaUEC _bspa _dES-MaUEC
050		4	_aRC280.E55 _bA236 2018 EB
245	0	0	_aAbdominal Neuroendocrine Tumors _cedited by Massimo Carlini
264		1	_aMilano _bSpringer International Publishing _c2018
300			_a1 recurso en línea (200 páginas, 20 ilustraciones, 10 ilustraciones a color)
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aUpdates in Surgery _x2280-9848
490	0		_aMedicine (Springer-11650)
505	0		_aForeword -- Preface -- 1 Anatomophysiology of the neuroendocrine system: Embryology, Anatomy - Histology - Citology, Physiology -- 2 Epidemiology: Risk factors -- 3 Classification: WHO (grading), site -- 4 Pathology: Anatomic pathology, Immunohistochemistry. - 5 Molecular biology: Molecular pathways, Oncogenes, Suppressor genes -- 6 Clinical presentations: Non functioning NETs -- 7 Clinical presentations: Hormone releasing NETs (Carcinoid syndrome, Insulinoma, Glucagonoma, VIPoma, Somatostatinoma, Others, GRFoma -- 8 MEN 1, MEN 2am, MEN 2b, and Others (TSC, VHL, NF1) -- 9 Diagnosis: (Serum biomarkers, Endoscopy, Imaging (US, CT Scan, MRI, Angiography, Scintigraphy, PET) -- 10 Staging: TNM -- 11 Surgical treatment: Gastric NETs, Duodenum NETs, Jejuno-ileal NETs, Colorectal NETs, Pancreatic NETs (Head, Body-tail), Adrenal NETs -- 12 Non surgical treatments: Chemotherapy, Hormonal syndrome treatment, Targeted therapies, IFN -- 13 Metastatic disease: Liver metastases (Surgery, RF ablation and cryoablation, Arterial chemoembolization) -- 14 Systemic therapy (Somatostatina analogs, Alpha IFN, Cytotoxic chemotherapy, Peptide receptor radiotherapy, VEGF inhibitors, mTOR inhibitors -- 15 Flow-charts.
520	3		_aThis book aims to equip readers with a better understanding of neuroendocrine tumors of the abdomen and explains how to manage them optimally by making use of novel therapeutic options that represent major advances on previous treatments. The most recent advances in epidemiology, genetics, molecular biology, biomarkers, pathology, diagnostics, clinical assessment, medical therapy, and surgical treatment are presented. The information and data provided will stimulate readers to develop their personal opinions on significant issues and assist in decision making in individual patients during routine clinical practice. The book features a multidisciplinary approach and is designed to meet the needs of all physicians seeking comprehensive guidance from experts on the management of patients with neuroendocrine tumors. It will also be of value for researchers wishing to acquaint themselves with the state of the art in the field and emerging research avenues. Abdominal Neuroendocrine Tumors is published in Springer's highly successful Updates in Surgery series, which now comprises more than 20 titles.
988			_aSpringer_Medicine_2018
650		7	_aGlándulas endocrinas _9302253 _2embne _xTumores
700	1		_aCarlini, Massimo _eeditor literario _0http://id.loc.gov/authorities/names/n2018021699 _0http://viaf.org/viaf/29867635
776	0	8	_iEdición impresa: _z9788847039711
776	0	8	_iEdición impresa: _z9788847039544
776	0	8	_iEdición impresa: _z9788847039568
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-88-470-3955-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b06/2019 _dz _ea _feng _ggw _h0